Does EDOXABAN Cause Off label use? 211 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 211 reports of Off label use have been filed in association with EDOXABAN (SAVAYSA). This represents 2.5% of all adverse event reports for EDOXABAN.
211
Reports of Off label use with EDOXABAN
2.5%
of all EDOXABAN reports
23
Deaths
96
Hospitalizations
How Dangerous Is Off label use From EDOXABAN?
Of the 211 reports, 23 (10.9%) resulted in death, 96 (45.5%) required hospitalization, and 6 (2.8%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EDOXABAN. However, 211 reports have been filed with the FAERS database.
What Other Side Effects Does EDOXABAN Cause?
Anaemia (663)
Cerebral infarction (419)
Gastrointestinal haemorrhage (378)
Renal impairment (359)
Cerebrovascular accident (337)
Dyspnoea (331)
General physical health deterioration (315)
Haematuria (312)
Fall (298)
Cardiac failure (272)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which EDOXABAN Alternatives Have Lower Off label use Risk?
EDOXABAN vs EDOXABAN TOSILATE
EDOXABAN vs EFALIZUMAB
EDOXABAN vs EFANESOCTOCOG ALFA
EDOXABAN vs EFAVIRENZ
EDOXABAN vs EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL